Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03616574
Title First-in-human Study of CA102N Monotherapy and of CA102N Combined With Trifluridine/Tipiracil (LONSURF) in Subjects With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Holy Stone Healthcare Co., Ltd

colorectal cancer

Advanced Solid Tumor



CA102N + Trifluridine-tipiracil hydrochloride

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.